Literature DB >> 11720479

Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor.

I Vande Broek1, K Vanderkerken, C De Greef, K Asosingh, N Straetmans, B Van Camp, I Van Riet.   

Abstract

The 67 kD laminin receptor (67LR) binds laminin-1 (LN), major component of the basement membrane, with high affinity. In this study, we demonstrated that human multiple myeloma cell lines (HMCL) and murine 5T2MM cells express 67LR. CD38(bright+) plasma cells in fresh multiple myeloma (MM) bone marrow (BM) samples showed weaker 67LR expression, but expression increased after direct exposure to a BM endothelial cell line (4LHBMEC). LN stimulated the in vitro migration of 3 HMCL (MM5.1, U266 and MMS.1), primary MM cells and the murine 5T2MM cells. 67LR has been shown to mediate the actions of LN through binding to CDPGYIGSR, a 9 amino acid sequence from the B1 chain of LN. MM cell migration was partially blocked by peptide 11, a synthetic nonapeptide derived from this amino sequence and also by a blocking antiserum against 67LR. Co-injection of peptide 11 with 5T2MM cells in a murine in vivo model of MM resulted in a decreased homing of 5T2MM cells to the BM compartment. In conclusion, LN acts as a chemoattractant for MM cells by interaction with 67LR. This interaction might be important during extravasation of circulating MM cells. Copyright 2001 Cancer Research Campaign

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720479      PMCID: PMC2375239          DOI: 10.1054/bjoc.2001.2078

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding.

Authors:  J Graf; Y Iwamoto; M Sasaki; G R Martin; H K Kleinman; F A Robey; Y Yamada
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

2.  Characteristics of established myeloma and lymphoblastoid cell lines derived from an E myeloma patient: a comparative study.

Authors:  K Nilsson
Journal:  Int J Cancer       Date:  1971-05-15       Impact factor: 7.396

3.  A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67,000 laminin receptor.

Authors:  J Graf; R C Ogle; F A Robey; M Sasaki; G R Martin; Y Yamada; H K Kleinman
Journal:  Biochemistry       Date:  1987-11-03       Impact factor: 3.162

4.  YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation.

Authors:  Y Iwamoto; F A Robey; J Graf; M Sasaki; H K Kleinman; Y Yamada; G R Martin
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

5.  Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies.

Authors:  I Van Riet; C Heirman; P Lacor; M De Waele; K Thielemans; B Van Camp
Journal:  Br J Haematol       Date:  1989-11       Impact factor: 6.998

6.  Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice.

Authors:  J Radl; E D De Glopper; H R Schuit; C Zurcher
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

7.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

8.  Role of laminin receptor in tumor cell migration.

Authors:  U M Wewer; G Taraboletti; M E Sobel; R Albrechtsen; L A Liotta
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

9.  Stimulation of murine tumour cell motility by laminin.

Authors:  R Situ; E C Lee; J P McCoy; J Varani
Journal:  J Cell Sci       Date:  1984-08       Impact factor: 5.285

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  18 in total

1.  Salmonella SiiE prevents an efficient humoral immune memory by interfering with IgG+ plasma cell persistence in the bone marrow.

Authors:  Christian Männe; Akiko Takaya; Yuzuru Yamasaki; Mathias Mursell; Shintaro Hojyo; Tsung-Yen Wu; Jana Sarkander; Mairi A McGrath; Rebecca Cornelis; Stefanie Hahne; Qingyu Cheng; Tadafumi Kawamoto; Falk Hiepe; Stefan H E Kaufmann; Tomoko Yamamoto; Andreas Radbruch; Koji Tokoyoda
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

2.  Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.

Authors:  Masood A Shammas; Paola Neri; Hemanta Koley; Ramesh B Batchu; Robert C Bertheau; Vidit Munshi; Rao Prabhala; Mariateresa Fulciniti; Yu Tzu Tai; Steven P Treon; Raj K Goyal; Kenneth C Anderson; Nikhil C Munshi
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

3.  Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy.

Authors:  Sébastien Goudenege; Yann Lamarre; Nicolas Dumont; Joël Rousseau; Jérôme Frenette; Daniel Skuk; Jacques P Tremblay
Journal:  Mol Ther       Date:  2010-08-03       Impact factor: 11.454

4.  37-kDa laminin receptor precursor mediates GnRH-II-induced MMP-2 expression and invasiveness in ovarian cancer cells.

Authors:  Song Ling Poon; Christian Klausen; Geoffrey L Hammond; Peter C K Leung
Journal:  Mol Endocrinol       Date:  2010-12-30

5.  C6orf106 enhances NSCLC cell invasion by upregulating vimentin, and downregulating E-cadherin and P120ctn.

Authors:  Xiupeng Zhang; Yuan Miao; Xinmiao Yu; Yong Zhang; Guiyang Jiang; Yang Liu; Juanhan Yu; Qiang Han; Huanyu Zhao; Enhua Wang
Journal:  Tumour Biol       Date:  2015-03-04

6.  Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression.

Authors:  Rehan Khan; Nidhi Gupta; Raman Kumar; Manoj Sharma; Lalit Kumar; Alpana Sharma
Journal:  Clin Exp Metastasis       Date:  2014-05-08       Impact factor: 5.150

Review 7.  Extravasation and homing mechanisms in multiple myeloma.

Authors:  Isabelle Vande Broek; Karin Vanderkerken; Benjamin Van Camp; Ivan Van Riet
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

8.  Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.

Authors:  Angela Pennisi; Xin Li; Wen Ling; Sharmin Khan; Dana Gaddy; Larry J Suva; Bart Barlogie; John D Shaughnessy; Nazneen Aziz; Shmuel Yaccoby
Journal:  Br J Haematol       Date:  2009-04-08       Impact factor: 6.998

9.  Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma.

Authors:  Kewal Asosingh; Eline Menu; Els Van Valckenborgh; Isabelle Vande Broek; Ivan Van Riet; Ben Van Camp; Karin Vanderkerken
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  A novel biomarker C6orf106 promotes the malignant progression of breast cancer.

Authors:  Guiyang Jiang; Xiupeng Zhang; Yong Zhang; Liang Wang; Chuifeng Fan; Hongtao Xu; Yuan Miao; Enhua Wang
Journal:  Tumour Biol       Date:  2015-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.